Call Options Transactions Made in Q3 2024 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q3 2024. The information is specifically focused on institutions that hold call options of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
278KNew |
$869K - $1.27M
|
278K
$885K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
255K+ 217.78% |
$795K - $1.16M
|
372K
$1.18M
|
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
BUY
|
CALL |
32.4K+ 11.37% |
$101K - $148K
|
317K
$1.01M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
30.6K+ 129.11% |
$95.5K - $140K
|
54.3K
$173K
|
|
|
Nov 13, 2024
Q3 2024
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
21.2KNew |
$66.1K - $96.7K
|
21.2K
$67.4K
|
|
|
Nov 14, 2024
Q3 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
CALL |
-175K- 12.11% |
$546K - $798K
|
1.27M
$4.04M
|